Literature DB >> 31931477

Hypoglycaemia-free artificial pancreas project.

Nicolas Magdelaine1, Pablo S Rivadeneira2, Lucy Chaillous3, Anne-Laure Fournier-Guilloux3, Michel Krempf3, Taghreed MohammadRidha4, Mourad Ait-Ahmed5, Claude H Moog6.   

Abstract

Driving blood glycaemia from hyperglycaemia to euglycaemia as fast as possible while avoiding hypoglycaemia is a major problem for decades for type-1 diabetes and is solved in this study. A control algorithm is designed that guaranties hypoglycaemia avoidance for the first time both from the theory of positive systems point of view and from the most pragmatic clinical practice. The solution consists of a state feedback control law that computes the required hyperglycaemia correction bolus in real-time to safely steer glycaemia to the target. A rigorous proof is given that shows that the control-law respects the positivity of the control and of the glucose concentration error: as a result, no hypoglycaemic episode occurs. The so-called hypo-free strategy control is tested with all the UVA/Padova T1DM simulator patients (i.e. ten adults, ten adolescents, and ten children) during a fasting-night scenario and in a hybrid closed-loop scenario including three meals. The theoretical results are assessed by the simulations on a large cohort of virtual patients and encourage clinical trials.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31931477      PMCID: PMC8687212          DOI: 10.1049/iet-syb.2018.5069

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  17 in total

1.  Automation control of blood sugar a servomechanism for glucose monitoring and control.

Authors:  A H KADISH
Journal:  Trans Am Soc Artif Intern Organs       Date:  1963

2.  Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.

Authors:  Malgorzata E Wilinska; Hood Thabit; Roman Hovorka
Journal:  IEEE Trans Biomed Eng       Date:  2016-09-08       Impact factor: 4.538

3.  Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.

Authors:  Ravi Gondhalekar; Eyal Dassau; Francis J Doyle
Journal:  Automatica (Oxf)       Date:  2016-06-01       Impact factor: 5.944

4.  In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.

Authors:  Boris P Kovatchev; Marc Breton; Chiara Dalla Man; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2009-01

5.  Analysis, modeling, and simulation of the accuracy of continuous glucose sensors.

Authors:  Marc Breton; Boris Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2008-09

6.  Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.

Authors:  John Walsh; Ruth Roberts; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

Review 7.  Artificial pancreas: past, present, future.

Authors:  Claudio Cobelli; Eric Renard; Boris Kovatchev
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461

8.  A robust fixed point transformation-based approach for type 1 diabetes control.

Authors:  Levente Kovács
Journal:  Nonlinear Dyn       Date:  2017-06-19       Impact factor: 5.022

9.  Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system.

Authors:  Ling Hinshaw; Chiara Dalla Man; Debashis K Nandy; Ahmed Saad; Adil E Bharucha; James A Levine; Robert A Rizza; Rita Basu; Rickey E Carter; Claudio Cobelli; Yogish C Kudva; Ananda Basu
Journal:  Diabetes       Date:  2013-02-27       Impact factor: 9.461

Review 10.  Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?

Authors:  Sara Trevitt; Sue Simpson; Annette Wood
Journal:  J Diabetes Sci Technol       Date:  2016-05-03
View more
  2 in total

1.  Interval Safety Layer Coupled With an Impulsive MPC for Artificial Pancreas to Handle Intrapatient Variability.

Authors:  María F Villa-Tamayo; Maira García-Jaramillo; Fabian León-Vargas; Pablo S Rivadeneira
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-21       Impact factor: 5.555

2.  Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes.

Authors:  Loïc Olçomendy; Louis Cassany; Antoine Pirog; Roberto Franco; Emilie Puginier; Manon Jaffredo; David Gucik-Derigny; Héctor Ríos; Alejandra Ferreira de Loza; Julien Gaitan; Matthieu Raoux; Yannick Bornat; Bogdan Catargi; Jochen Lang; David Henry; Sylvie Renaud; Jérôme Cieslak
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.